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Introduction: Systemic sclerosis is a systemic connective tissue disease with variable cutaneous presentations.
Although pigmentary disturbances have been described in systemic sclerosis, a reticulate hyperpigmentation has
only been reported in one case of systemic sclerosis to date.
Case presentation: We describe a previously healthy 51-year-old Thai woman who presented with a reticulate
hyperpigmentation affecting her trunk and extremities, together with sclerodactyly and proximal sclerosis, resulting
in a new diagnosis of systemic sclerosis.
Conclusions: To date, the pathogenesis of reticulate hyperpigmentation in systemic sclerosis remains unclear. Increased
melanin synthesis and altered thermoregulatory mechanism are proposed to be involved in the pathogenesis of this
presentation. This case represents an unusual cutaneous feature of reticulate hyperpigmentation in the setting of
systemic sclerosis.
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Systemic sclerosis (SSc) is a multisystem rheumatic dis-
ease with a variable clinical presentation. Clinical diag-
nosis is mainly based on the presence of skin thickening
and variable involvement of internal organs. Various cu-
taneous pigmentary alterations have been described in
SSc [1], including a diffuse, generalized hyperpigmentation
with accentuation in sun-exposed areas, a vitiligo-like de-
pigmentation with perifollicular hyperpigmentation, and a
combined hyper- and hypopigmentation in the areas of
sclerosis [2–6]. The pattern of reticulate hyperpigmentation
in SSc has been rarely reported in the literature, and has an
unclear pathogenesis. We report an unrecognized pig-
mentary abnormality in a 51-year-old patient with SSc
who presented with a reticulate hyperpigmentation af-
fecting the trunk and all extremities. To date, there
have been only a few cases of reticulate hyperpig-
mented scleroderma reported in the English literature.* Correspondence: penvadee.pat@mahidol.ac.th
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Our patient, a 51-year-old Thai woman, presented with
a 1-year history of progressively evolving skin pigmenta-
tion over her body, which had become accentuated over
her trunk and extremities during the past few months.
She also complained of appetite loss resulting in an un-
intentional weight loss of 8kg (17.6lbs) in 1 year, joint
pain in her wrists and ankles, and bilateral hand swell-
ing. Our patient also reported the presence of Raynaud’s
phenomenon (RP) during the wintertime that had oc-
curred about 5 years prior to the skin change of the
hands. There were no other remarkable systemic symp-
toms. Our patient had been previously healthy and did
not take any medications. There was no familial history
of a similar skin condition or history of chemical expos-
ure in this case. A physical examination revealed a gen-
eralized, reticulate hyperpigmentation and indurated
erythematous plaques over her trunk and extremities.
Additionally, there was sclerosis of her proximal fingers,
sclerodactyly with pitted scars on some fingertips, and
Raynaud’s phenomenon (Fig. 1a-c). Nailfold capillaro-
scopy was performed and showed few capillary loops
dilatation without significant tortuosity. Telangiectasia
and calcinosis cutis were absent in this patient. There
was no evidence of additional systemic involvement.his article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Clinical presentation. a, b Widespread reticulate hyperpigmentation over the trunk and extremities with discrete erythematous indurated
plaques over the chest wall and anterior abdomen, c Sclerodactyly with cool periphery of all fingers
Fig. 2 Histopathological findings. A biopsy from the hyperpigmented
induration on the right thigh showed increased basal pigmentation
with pan-dermal sclerosis. Mild superficial and deep perivascular and
perieccrine lymphocytic infiltrate was observed with some dilated
dermal blood vessels and decreased adventitious fat surrounding sweat
glands. (Hematoxylin and eosin, ×10 objective)
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count, creatinine, electrolytes, fasting blood sugar, thyroid
function, and liver function. An elevated erythrocyte
sedimentation rate (ESR) of 40mm/hour (reference range
0–20mm/hour), a positive antinuclear antibody (ANA)
titer of 1:640 (coarse-speckled pattern), and a positive
rheumatoid factor (RF) >130IU/mL (reference range; <12.5IU/
mL=negative, 12.5–20.5IU/mL=borderline, >20.5IU/mL=
positive) were detected. Anti-centromere antibody (ACA),
anti-topoisomerase I antibody (anti-Scl-70 Ab), anti-
dsDNA antibody, anti-RNP antibody, anti-cardiolipin anti-
body (immunoglobulin G (IgG) and IgM), lupus anticoagu-
lant, anti-β2-glycoprotein 1 antibody (anti-β2-GP1 Ab),
and anti-cyclic citrullinated peptide antibody (anti-CCP
Ab) tests revealed negative results. Urinalysis, chest X-ray,
pulmonary function test, and upper gastrointestinal endos-
copy results were normal. A skin biopsy specimen from
her right calf corresponding to the hyperpigmented indur-
ation showed hyperpigmentation of basal keratinocytes
and broad sclerotic collagen bundles involving full thick-
ness of the dermis, replacing adventitious fat, and extend-
ing into the subcutis with mild septal thickening (Fig. 2).
Some ectatic capillary blood vessels were found in the
superficial and deep reticular dermis without evidence of
vasculitis or vasculopathy. A superficial and deep perivas-
cular infiltrate composed of lymphocytes, plasma cells, and
some eosinophils was noted. Based upon the clinical com-
bination of sclerodactyly with sclerosis of the proximalfingers, generalized reticulate hyperpigmentation, and
histopathological finding of pan-dermal sclerosis, reticu-
late hyperpigmented systemic sclerosis was diagnosed.
Discussion
Reticulate hyperpigmentation is characterized by mottled
patterns of cutaneous hyperpigmentation. The etiology is
Table 1 Clinicopathological presentation and management of reticulate hyperpigmented scleroderma
Previous case [2] Previous case [3] Previous case [3] Present case
Age (year) , sex 48, female 47, male 43, male 51, female
Signs and
symptoms
Raynaud’s phenomenon, dsyphagia, sclerodactyly,
periungual telangiectasias, mask-like facies with
perioral radial furrows; new diagnosis of systemic
sclerosis
Porcelain-white, sclerotic bands in a
reticulate pattern and painful ulcerations;
associated with melphalan











Chest, abdomen and back Medial aspect of the left thigh and upper
calf
Medio-popliteal aspect of the
right thigh
Trunk and extremities
ANA Negative n/a n/a Positive, titer 1:640 (speckled pattern)
Anti-centromere
Ab
Negative n/a n/a Negative
Anti-Scl-70 Ab Negative n/a n/a Negative
Anti-cardiolipin Ab Negative n/a n/a Negative
Histological findings
Epidermis Epidermal atrophy and basal pigmentation Epidermal atrophy n/a Basal hyperpigmentation
Dermis and
subcutis
Thickened sclerotic collagen, marked pigmentary
incontinence with numerous melanophages in the
upper dermis, septal thickening
Thickened, intensely eosinophilic and
closely packed collagen bundles
n/a Broad sclerotic collagen bundles in dermis
replacing adventitious fat, superficial and
deep perivascular lymphoplasmacytic
infiltrate with few eosinophils, mild
septal thickening
Treatment n/a Topical corticosteroids and antibiotics
under a hydrocolloid dressing
Hydrocolloid dressing and
topical antibiotics
Topical corticosteroid, colchicine, aspirin,
nifedipine, vitamin E, hydroxychloroquin
UVA1 phototherapy
Follow-up n/a Recovery of the ulcers n/a Improvement of thickened skin and
Raynaud’ s phenomenon
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approach to identify the causes of reticulate hyperpigmen-
tation depends on the characteristic onset of the disease,
the distribution of lesion, and the associated clinical find-
ings. Further investigations including a skin biopsy may be
helpful for the definitive diagnosis [1]. There are several
patterns of pigmentary alteration previously described in
sclerodermic patients, which are: i) diffuse generalized
hyperpigmentation, similar to Addison’s disease; ii) focal
depigmentation with perifollicular hyperpigmentation,
resembling vitiligo; iii) localized hypo- and hyperpigmen-
tation in localized sclerotic skin; iv) streaky hyperpigmenta-
tion over blood vessels on a background of depigmentation
on the legs and temporal scalp; and v) the most recent
condition termed “reticulate hyperpigmented scleroderma”
[2–6]. The pathogenesis of these hyperpigmentation abnor-
malities remains unclear, but some proposed hypotheses in-
clude increased keratinocyte-derived endothelin-1 (ET-1),
increased melanin synthesis; increased secretion of melano-
cytic growth factors by fibroblasts and endothelial cells; and
a thermoregulatory mechanism which results in a hyperpig-
mentation over vessels (“streaky hyperpigmentation”) on a
background of depigmented patches [4, 7–9]. Histopatho-
logical findings to explain hyperpigmentation in SSc have
been previously reported as increased epidermal melanin
and pigmentary incontinence with an increased number of
dermal melanophages in the superficial dermis [10]. How-
ever, in this present case, the lesional skin biopsy showed
prominent basal hyperpigmentation without evidence of
melanin incontinence or increased dermal melanophages.
The presence of some indurated erythematous plaques
over the trunk and extremities is quite uncommon re-
garding sclerotic skin change in SSc, and therefore the
differential diagnosis with generalized morphea or other
scleroderma-mimic conditions such as eosinophilic fasci-
itis, sclerodermiform genodermatoses, scleroderma-like
syndromes induced by environmental factors, scleroderma
diabeticorum, nephrogenic systemic fibrosis, graft-versus-
host disease, and scleroderma-like lesions in malignancies
also is concerned. Thus, the absent history of underlying
systemic diseases including diabetes, chronic kidney dis-
ease, malignancy or substance exposures and the recent
onset of cutaneous symptoms would render the diagnosis
of SSc regardless of other etiology. Moreover, the presence
of sclerodactyly, RP and abnormal nailfold capillaroscopy
support the diagnosis of SSc in our case.
To date, there have been only three reported cases of
reticulate hyperpigmented scleroderma. Of these reports,
two cases were the result of melphalan-induced localized
reticulate scleroderma, which occurred secondary to
isolated limb perfusion for treatment of malignancies in
patients who did not have a history of SSc or other con-
nective tissue diseases [2, 3]. These patients presented
with localized porcelain-white sclerotic bands in a fishnetpattern, which was due to melphalan-induced endothelial
injury. Ee et al. reported the only other known case to
date of reticulate hyperpigmented scleroderma arising in
the setting of SSc, and was that of a 48-year-old woman
[2]. The pathogenesis remains unclear and further study is
required to identify the mechanism of reticulate pigmen-
tary change in SSc. The thermovascular influence, as sug-
gested by Jawitz et al., is one of the possible mechanisms
[4]; however, the skin biopsy in our patient did not reveal
the presence of vasculitis or vasculopathy. The only
vascular-related changes seen in the biopsy was the dila-
tion of dermal vasculature, which was surrounded by
sclerotic collagen within the dermis.
In summary, our patient is the second reported case of
reticulate hyperpigmented scleroderma, and the first case
to provide outcome information. Our patient has been
treated and responded well to a combination therapy of
topical potent corticosteroids, ultraviolet A1 (UVA1) photo-
therapy, and daily oral medication with colchicine 1.2mg,
aspirin 80mg, nifedipine 30mg, vitamin E 400mg, and
hydroxychloroquin 200mg. Improvement of the skin hard-
ening and RP were observed after 3 months of treatment.
However, our patient reported occasional exacerbation of
RP during the winter. The comparative case information
between the previous case reports and our case is shown in
Table 1.
Conclusions
Reticulate hyperpigmented scleroderma is a distinctly rare
cutaneous presentation in association with systemic scler-
osis. The pathogenesis is uncertain. Unlike the previously
reported case of reticulate hyperpigmentation in association
with systemic sclerosis, our patient failed to demonstrate
the presence of vascular alterations or melanin incontin-
ence in the skin biopsy. Further studies are necessary to
evaluate the mechanism of this peculiar pigmentary change
in systemic sclerosis.
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